Nexthera Capital as of Sept. 30, 2018
Portfolio Holdings for Nexthera Capital
Nexthera Capital holds 54 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| SPDR S&P Biotech (XBI) | 18.4 | $96M | 1.0M | 95.87 | |
| Exelixis (EXEL) | 5.9 | $31M | 1.7M | 17.72 | |
| Allergan | 5.8 | $30M | 159k | 190.48 | |
| Immunomedics | 5.6 | $29M | 1.4M | 20.83 | |
| BioMarin Pharmaceutical (BMRN) | 5.6 | $29M | 300k | 96.97 | |
| Mylan Nv | 4.9 | $26M | 696k | 36.60 | |
| Dova Pharmaceuticals | 4.1 | $22M | 1.0M | 20.97 | |
| Audentes Therapeutics | 4.1 | $21M | 541k | 39.59 | |
| Global Blood Therapeutics In | 4.0 | $21M | 549k | 38.00 | |
| Cara Therapeutics (CARA) | 3.4 | $18M | 737k | 23.95 | |
| Insmed (INSM) | 2.8 | $14M | 714k | 20.22 | |
| Bausch Health Companies (BHC) | 2.7 | $14M | 546k | 25.67 | |
| Endocyte | 2.2 | $12M | 655k | 17.76 | |
| ACADIA Pharmaceuticals (ACAD) | 2.2 | $11M | 544k | 20.76 | |
| Abeona Therapeutics | 2.1 | $11M | 850k | 12.80 | |
| Cymabay Therapeutics | 1.9 | $10M | 909k | 11.08 | |
| ArQule | 1.9 | $9.8M | 1.7M | 5.66 | |
| D Stemline Therapeutics | 1.9 | $9.7M | 582k | 16.60 | |
| Catalyst Biosciences | 1.8 | $9.6M | 893k | 10.78 | |
| Therapeuticsmd | 1.6 | $8.6M | 1.3M | 6.56 | |
| Nektar Therapeutics (NKTR) | 1.5 | $7.8M | 128k | 60.96 | |
| AstraZeneca (AZN) | 1.5 | $7.6M | 193k | 39.57 | |
| Achillion Pharmaceuticals | 1.1 | $5.8M | 1.6M | 3.68 | |
| Viking Therapeutics (VKTX) | 1.1 | $5.7M | 328k | 17.42 | |
| Kura Oncology (KURA) | 1.0 | $5.5M | 312k | 17.50 | |
| Eli Lilly & Co. (LLY) | 1.0 | $5.4M | 50k | 107.32 | |
| Pfizer (PFE) | 1.0 | $5.3M | 120k | 44.07 | |
| Foamix Pharmaceuticals | 0.8 | $4.3M | 747k | 5.73 | |
| Zosano Pharma Corp | 0.8 | $4.2M | 1.0M | 4.09 | |
| Sutro Biopharma (STRO) | 0.7 | $3.5M | 232k | 15.00 | |
| Iovance Biotherapeutics (IOVA) | 0.6 | $3.3M | 297k | 11.25 | |
| Fibrogen (FGEN) | 0.6 | $3.1M | 50k | 60.76 | |
| Heron Therapeutics (HRTX) | 0.5 | $2.8M | 90k | 31.65 | |
| Tg Therapeutics (TGTX) | 0.5 | $2.5M | 445k | 5.60 | |
| Sesen Bio | 0.5 | $2.5M | 1.2M | 2.15 | |
| Chiasma | 0.4 | $2.3M | 637k | 3.60 | |
| Oncosec Med | 0.4 | $1.9M | 1.4M | 1.40 | |
| Magenta Therapeutics | 0.3 | $1.8M | 150k | 12.01 | |
| Neos Therapeutics | 0.3 | $1.5M | 312k | 4.85 | |
| Oncomed Pharmaceuticals | 0.3 | $1.3M | 635k | 2.12 | |
| Synergy Pharmaceuticals | 0.2 | $1.3M | 746k | 1.70 | |
| Deciphera Pharmaceuticals (DCPH) | 0.2 | $1.2M | 31k | 38.73 | |
| Clearside Biomedical (CLSD) | 0.2 | $1.1M | 181k | 6.15 | |
| Savara (SVRA) | 0.2 | $1.1M | 98k | 11.16 | |
| Mediwound Ltd cmn | 0.2 | $1.1M | 173k | 6.15 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.2 | $1.0M | 53k | 19.35 | |
| Acorda Therapeutics | 0.2 | $983k | 50k | 19.66 | |
| Adaptimmune Therapeutics (ADAP) | 0.2 | $1.0M | 74k | 13.56 | |
| Madrigal Pharmaceuticals (MDGL) | 0.2 | $857k | 4.0k | 214.25 | |
| Keryx Biopharmaceuticals | 0.1 | $680k | 200k | 3.40 | |
| Molecular Templates | 0.1 | $569k | 106k | 5.39 | |
| Akorn | 0.1 | $454k | 35k | 12.97 | |
| Immune Design | 0.0 | $146k | 42k | 3.45 | |
| Vaccinex | 0.0 | $124k | 17k | 7.27 |
